Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Product Details
Alternative Name |
DR5, TNFRSF 10B, KILLER, CD262 |
---|---|
Application Notes |
Flow Cytometry: detection of TRAIL cell surface expression. |
Biological Activity |
Inhibits human soluble TRAIL-mediated apoptosis. |
Concentration |
1mg/ml. |
Endotoxin Content |
<0.1EU/µg purified protein (LAL test; Bio Whittaker). |
Formulation |
Liquid. In PBS containing 0.02% sodium azide. |
MW |
~46kDa (SDS-PAGE). |
Purity |
≥95% (SDS-PAGE) |
Source |
Produced in HEK 293 cells. The extracellular domain of human TRAIL-R2 (DR5) (aa 52-212) is fused to the Fc portion of human IgG1. |
Specificity |
Binds human and mouse TRAIL. |
Technical Info / Product Notes |
Historical data has shown inhibition of human soluble TRAIL-induced apoptosis in a concentration range of 0.5-10µg/ml. |
UniProt ID |
O14763 |
Handling & Storage
Use/Stability |
Stable for at least 6 months after receipt when stored at -20°C. |
---|---|
Handling |
Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -20°C. |
Long Term Storage |
-20°C |
Shipping |
Blue Ice |
Regulatory Status |
RUO – Research Use Only |
---|
- JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand: Mucha, S. R., Rizzani, A., et al.; Gut 58, 688 (2009), Abstract
- Two adjacent trimeric fas ligands are required for fas signaling and formation of a death-inducing signaling complex: N. Holler, et al.; Mol. Cell. Biol. 23, 1428 (2003), Abstract — Full Text
- Induction of TRAIL-mediated glioma cell death by human T cells: J. Dörr, et al.; J. Neuroimmunol. 122, 117 (2002), Abstract
- Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells: J.D. Lunemann, et al.; J. Immunol. 168, 4881 (2002), Abstract — Full Text
- Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand: G. Lu, et al.; J. Immunol. 168, 1831 (2002), Abstract — Full Text
- Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Signaling in Activated T Cells Abrogates TRAIL-Induced Apoptosis Upstream of the Mitochondrial Amplification Loop and Caspase-8: T.S. Soderstrom, et al.; J. Immunol. 169, 2851 (2002), Abstract
- T cells require TRAIL for optimal graft-versus-tumor activity: C. Schmaltz, et al.; Nat. Med. 8, 1433 (2002), Abstract
- TRAIL/Apo-2 ligand induces primary plasma cell apoptosis: J. Ursini-Siegel, et al.; J. Immunol. 169, 5505 (2002), Abstract — Full Text
- The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation: F. Mühlenbeck, et al.; J. Biol. Chem. 275, 32208 (2000), Abstract — Full Text
- Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors: N. Holler, et al.; J. Immunol. Methods 237, 159 (2000), Abstract
Related Products

Alternative Name | DR5, TNFRSF 10B, KILLER, CD262 |
---|---|
Purity | ≥95% (SDS-PAGE) |
Source | Produced in HEK 293 cells. The extracellular domain of human TRAIL-R2 (DR5) (aa 52-212) is fused to the Fc portion of human IgG1. |
Control:Fc fusion protein (human), (recombinant)
ALX-203-004
Negative control for Fc chimeric proteins

Alternative Name | Thy-1 (RLE mutant) |
---|---|
Purity | ≥90% (SDS-PAGE) |
Source | Produced in HEK 293 cells. The extracellular domain of mutated hThy-1, hThy-1 (RLE) (aa 20-130), is fused to the Fc portion of human IgG1. The integrin binding sequence RLD of hThy-1 has been changed to RLE abolishing the binding of integrins. |
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form